Low dose radiotherapy has been used in the pre-antibiotic era for the treatment of all kind of
pneumonia, with relative success. The unimaginable daily death toll of thousands of victims …

SARS-CoV-2 is a novel human coronavirus, first observed at the end of December 2019 in
China. In March 2020, with the outbreak of the epidemic, the World Health Organization …

Background Individuals of advanced age with comorbidities face a higher risk of death from
coronavirus disease 2019 (COVID‐19), especially once they are ventilator‐dependent …

The acute respiratory distress syndrome (ARDS) induced by SARS-CoV-2-mediated
cytokine storm (CS) in lungs leads to the high mortality in COVID-19 patients. To reduce …

Patients with severe COVID-19 have a marked inflammatory state characterized by a
cytokine storm syndrome. Severe pneumonia and acute respiratory distress syndrome …

Purpose It seems that 2020 would be always remembered by the name of novel coronavirus
(designated as SARS-CoV-2), which exerted its deteriorating effects on the health care …

Fatal cases of COVID-19 are characterised by acute respiratory distress syndrome (ARDS),
sepsis, pneumonia and respiratory failure [1]. The high transmission rate of the virus and the …

Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), a highly pathogenic and
transmissible virus, has spurred an impressive accumulation of knowledge [1–3]. The …

The COVID-19 pandemia is affecting people worldwide. Most of the patients suffered of a
respiratory disease that will progress to an acute respiratory distress syndrome (ARDS) …

An unprecedented global pandemic caused by a novel coronavirus named SARS-CoV-2
has created a severe healthcare threat and become one of the biggest challenges to human …